Early Menopause After Cancer Treatment

Menopause has a plain definition. You have reached it when 12 months pass with no period. Most women reach it between 45 and 55.

Two words describe reaching it sooner. Early menopause means before age 45. Premature menopause means before age 40. Clinicians often call the second one primary ovarian insufficiency, or POI.

Cancer treatment can set this off at 27 or at 34. The symptoms are the ordinary ones. The arithmetic is not. You may face twenty extra years without estrogen. That shows up in bone and in blood vessels.

Missing periods during chemotherapy do not settle the question. Ovarian function sometimes returns months after the last cycle. Return is more likely in women under 35.

The workup has two parts. First, periods stop or turn irregular for roughly four to six months. Second, blood work shows follicle-stimulating hormone in the menopausal range. Follicle-stimulating hormone, or FSH, is the pituitary signal that tells the ovaries to ripen an egg. When ovaries stop answering that signal, the level climbs. StatPearls describes the threshold as two FSH values above 40 IU/L, drawn 30 days apart.

Anti-mullerian hormone, or AMH, estimates the eggs you have left. Most women with POI have an AMH under 1. AMH supports the picture but is not part of the formal criteria.

Removing both ovaries ends estrogen production the same day. There is no gradual slide.

Alkylating chemotherapy is the main drug cause. This class includes cyclophosphamide, busulfan, and melphalan. These drugs damage the resting pool of eggs. Risk rises with total dose and with your age at treatment.

Radiation can also stop ovarian function. The fields that matter are the pelvis, the reproductive organs, and the central nervous system. StatPearls reports that when radiation is combined with alkylating drugs, the risk of POI reaches about 30 percent.

Hormone-blocking treatment is a different case. Tamoxifen, aromatase inhibitors, and GnRH agonists all produce menopausal symptoms. Suppression from a GnRH agonist often lifts once the injections stop.

About two-thirds of postmenopausal women with a history of breast cancer report hot flashes. Night sweats travel with them in 44 percent of those women.

The NCI clinical summary groups drug options by how much they cut hot flashes. Four options reach a 55 to 60 percent reduction:

• Venlafaxine
• Paroxetine, either the standard or the controlled-release form
• Gabapentin, begun at a low bedtime dose and stepped up slowly
• Pregabalin, also begun at bedtime and stepped up

Roughly 50 percent reduction comes from citalopram or fluoxetine. Escitalopram is also listed, though it was studied outside cancer care. Clonidine, taken by mouth or worn as a patch, reaches about 40 percent. Megestrol acetate is a hormonal option.

The strengths and the step-up schedule are not printed here on purpose. Each of these is started low and adjusted to how you respond, and the prescriber weighs your other medicines before picking one. What is useful to you is the list itself, so you can ask which of them suits your situation.

One interaction deserves a flag. Tamoxifen only works after the liver enzyme CYP2D6 converts it to endoxifen. Paroxetine blocks that enzyme. Taking the two together lowers endoxifen levels. Retrospective data tie longer overlap to higher mortality. If you take tamoxifen, say so before any antidepressant is started for hot flashes.

Two non-drug approaches have real trial numbers. In one randomized trial, medical hypnosis cut hot flash frequency by 64 percent at six weeks. Controls dropped 9 percent. By twelve weeks the split was 75 percent against 17 percent. In a trial of men on androgen deprivation therapy, guided self-help cognitive behavioral therapy cut hot flash and night sweat symptoms by 40 percent against 12 percent with usual care. In trials in women, CBT eased how much flashes bothered people but did not reliably change how often they came.

Several popular supplements did not hold up. Vitamin E at 400 IU twice daily gave a 35 to 40 percent drop, only marginally better than placebo. Soy, black cohosh, and flaxseed all matched placebo in randomized testing.

Falling estrogen thins vaginal tissue. Pelvic radiation adds its own damage. That includes dryness, atrophy, inflammation, and stenosis, which means the vagina narrows. Intercourse can become painful.

Four tools address this. Water-based lubricants such as K-Y Jelly or Astroglide work at the time of sex. Vaginal moisturizers work on a schedule, applied several times a week whether or not you have sex. Vaginal estrogen comes as a cream, gel, tablet, or ring. NCI notes it is appropriate for some cancer types, so raise it with your oncologist rather than assuming either answer. Dilators help prevent or reverse scarring after pelvic radiation or graft-versus-host disease.

Pelvic floor exercises are the fourth. NCI credits them with lowering pain and increasing blood flow to the area. They also improve bladder retention and bowel function.

Less estrogen means faster bone loss and higher fracture risk. Protection is unglamorous: weight-bearing exercise, enough calcium and vitamin D, bone density testing, and stopping smoking.

The larger risk is quieter. StatPearls puts the greatest health impact of POI on the heart. It drives early death from ischemic heart disease. So blood pressure, lipids, and glucose need a real schedule.

For POI without a hormone-sensitive cancer, replacement is framed as restoring what your body should still be making. StatPearls describes estradiol given by skin patch or by the vaginal route, at a strength your prescriber sets. Treatment usually runs to the average age of natural menopause. In the United States that is about 50.5 years. If you still have a uterus, progesterone must be added to protect the lining.

Hormone-receptor-positive breast cancer changes this conversation completely. Ask your oncologist, not a general provider working from standard menopause guidance.

Egg freezing, embryo freezing, and ovarian tissue freezing all work best before treatment starts. Ovarian transposition is a fourth option, also called oophoropexy. A surgeon moves the ovaries, and sometimes the tubes, out of a planned radiation field.

One caution runs the other way. Irregular periods are not proof of infertility. Ask what contraception you need until the diagnosis is confirmed.

• Call 911 or go to an emergency department if chest pressure, jaw or arm pain, or new shortness of breath appears.
• Call your care team the same day if any vaginal bleeding starts after 12 full months with no period, or new bone pain follows a minor fall or a lift you would normally handle.
• Call your care team within a day or two if hot flashes wake you more than three times a night for two weeks or more.

See Cancer and Fertility, Sexual Health and Cancer, and Fertility Preservation Before Cancer Treatment.

• https://medlineplus.gov/ency/patientinstructions/000912.htm
• https://medlineplus.gov/menopause.html
• https://www.cancer.gov/about-cancer/treatment/side-effects/sexuality-fertility-women/hot-flashes-hp-pdq
• https://www.cancer.gov/about-cancer/treatment/side-effects/sexuality-women
• https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women
• https://www.ncbi.nlm.nih.gov/books/NBK589674/